Vladislav Shestakov took part in the 8th International Pharmaceutical Congress Russia – Nicaragua “Evolution of Production Potential: Localization of Production to Strengthen the International Health Care System”

In his speech, Vladislav Shestakov emphasized that in order to prevent marketing of substandard medicines, a balance of regulatory supervision requirements and regulatory flexibility is needed, which is reached through readiness for changes that contribute to developing the regulatory system, and consequently to creating conditions for the growth of the local pharmaceutical industry and ensuring public access to medicines, including innovative ones.

Vladislav Shestakov noted that increasing the adaptability of the regulatory system, its patient-centeredness, the creation of a regulatory framework, contributes to the most rapid implementation of new regulatory tools.

The Congress is being held for the eighth time and over the years has become one of the most effective international platforms for discussing topical issues of regulation of medicines. This year, officers of the Pan American Health Organization, regulatory authorities and pharmaceutical companies of Cuba, China, and India are taking part in the event.